237 related articles for article (PubMed ID: 20460926)
21. Liver microsomal triglyceride transfer protein is involved in hepatitis C liver steatosis.
Mirandola S; Realdon S; Iqbal J; Gerotto M; Dal Pero F; Bortoletto G; Marcolongo M; Vario A; Datz C; Hussain MM; Alberti A
Gastroenterology; 2006 May; 130(6):1661-9. PubMed ID: 16697730
[TBL] [Abstract][Full Text] [Related]
22. Hepatocyte steatosis is an important predictor of response to interferon (IFN) monotherapy in Japanese patients infected with HCV genotype 2a: Virological features of IFN-resistant cases with hepatocyte steatosis.
Akuta N; Suzuki F; Suzuki Y; Sezaki H; Hosaka T; Someya T; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kobayashi M; Kumada H
J Med Virol; 2005 Apr; 75(4):550-8. PubMed ID: 15714492
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis C virus diversity and hepatic steatosis.
Roingeard P
J Viral Hepat; 2013 Feb; 20(2):77-84. PubMed ID: 23301542
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis C virus, diabetes and steatosis: clinical evidence in favor of a linkage and role of genotypes.
Mihm S
Dig Dis; 2010; 28(1):280-4. PubMed ID: 20460924
[TBL] [Abstract][Full Text] [Related]
25. An in vitro model of hepatitis C virus genotype 3a-associated triglycerides accumulation.
Abid K; Pazienza V; de Gottardi A; Rubbia-Brandt L; Conne B; Pugnale P; Rossi C; Mangia A; Negro F
J Hepatol; 2005 May; 42(5):744-51. PubMed ID: 15826725
[TBL] [Abstract][Full Text] [Related]
26. Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C.
Liu CJ; Chen PJ; Jeng YM; Huang WL; Yang WS; Lai MY; Kao JH; Chen DS
J Hepatol; 2005 Aug; 43(2):235-42. PubMed ID: 15964656
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis C and steatosis.
Björnsson E; Angulo P
Arch Med Res; 2007 Aug; 38(6):621-7. PubMed ID: 17613353
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis C virus-induced hepatocellular steatosis.
Castera L; Chouteau P; Hezode C; Zafrani ES; Dhumeaux D; Pawlotsky JM
Am J Gastroenterol; 2005 Mar; 100(3):711-5. PubMed ID: 15743372
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis C and steatosis.
Dev A; Patel K; McHutchison JG
Clin Liver Dis; 2004 Nov; 8(4):881-92, ix. PubMed ID: 15464660
[TBL] [Abstract][Full Text] [Related]
30. Hepatocyte steatosis in patients infected with genotype 1 hepatitis C virus.
Fierbinţeanu-Braticevici C; Mohora M; Tribus L; Petrişor A; Creţoiu SM; Creţoiu D; Usvat R; Ioniţă L
Rom J Morphol Embryol; 2010; 51(2):235-42. PubMed ID: 20495737
[TBL] [Abstract][Full Text] [Related]
31. [Pathomechanism of metabolic disorders in HCV infection].
Boroń-Kaczmarska A
Przegl Epidemiol; 2006; 60(4):701-5. PubMed ID: 17682751
[TBL] [Abstract][Full Text] [Related]
32. Influence of metabolic syndrome, viral genotype and antiviral therapy on superimposed fatty liver disease in chronic hepatitis C.
Liu CJ; Jeng YM; Chen PJ; Lai MY; Yang HC; Huang WL; Kao JH; Chen DS
Antivir Ther; 2005; 10(3):405-15. PubMed ID: 15918331
[TBL] [Abstract][Full Text] [Related]
33. Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C.
Cammà C; Bruno S; Di Marco V; Di Bona D; Rumi M; Vinci M; Rebucci C; Cividini A; Pizzolanti G; Minola E; Mondelli MU; Colombo M; Pinzello G; Craxì A
Hepatology; 2006 Jan; 43(1):64-71. PubMed ID: 16374856
[TBL] [Abstract][Full Text] [Related]
34. Microsomal triglyceride transfer protein polymorphism (-493G/T) is associated with hepatic steatosis in patients with chronic hepatitis C.
Mirandola S; Osterreicher CH; Marcolongo M; Datz C; Aigner E; Schlabrakowski A; Realdon S; Gerotto M; Alberti A; Stickel F
Liver Int; 2009 Apr; 29(4):557-65. PubMed ID: 19018985
[TBL] [Abstract][Full Text] [Related]
35. Morphological changes in intracellular lipid droplets induced by different hepatitis C virus genotype core sequences and relationship with steatosis.
Piodi A; Chouteau P; Lerat H; Hézode C; Pawlotsky JM
Hepatology; 2008 Jul; 48(1):16-27. PubMed ID: 18570290
[TBL] [Abstract][Full Text] [Related]
36. Steatosis in chronic hepatitis C: why does it really matter?
Asselah T; Rubbia-Brandt L; Marcellin P; Negro F
Gut; 2006 Jan; 55(1):123-30. PubMed ID: 16344578
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis C virus, steatosis and lipid abnormalities: clinical and pathogenic data.
Negro F; Sanyal AJ
Liver Int; 2009 Mar; 29 Suppl 2():26-37. PubMed ID: 19187070
[TBL] [Abstract][Full Text] [Related]
38. Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients.
Durante-Mangoni E; Zampino R; Marrone A; Tripodi MF; Rinaldi L; Restivo L; Cioffi M; Ruggiero G; Adinolfi LE
Aliment Pharmacol Ther; 2006 Nov; 24(9):1349-57. PubMed ID: 17059516
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis C virus infection and liver steatosis.
Ramalho F
Antiviral Res; 2003 Oct; 60(2):125-7. PubMed ID: 14638408
[TBL] [Abstract][Full Text] [Related]
40. Steatohepatitis is associated with diabetes and fibrosis in genotype 1b HCV-related chronic liver disease.
Masarone M; La Mura V; Bruno S; Gaeta GB; Vecchione R; Carrino F; Moschella F; Torella R; Persico M
J Viral Hepat; 2007 Oct; 14(10):714-20. PubMed ID: 17875006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]